XenoTherapeutics

Xeno Therapeutics

Biotechnology, 359 Newbury St, Boston, Massachusetts, 02115, United States, 1-10 Employees

xenotherapeutics.org

  • LinkedIn

phone no Phone Number: 16*********

Who is XENOTHERAPEUTICS

XenoTherapeutics is a not-for-profit, clinical-stage regenerative medicine company developing innovative cell and tissue-based research solutions. Our FDA-accepted pathogen screening and ...

Read More

map
  • 359 Newbury St, Boston, Massachusetts, 02115, United States Headquarters: 359 Newbury St, Boston, Massachusetts, 02115, United States
  • 2016 Date Founded: 2016
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8733 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from XENOTHERAPEUTICS

XenoTherapeutics Org Chart and Mapping

Employees

Mark Steffen

Senior Public Affairs / Media Relations Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding XenoTherapeutics

Answer: XenoTherapeutics's headquarters are located at 359 Newbury St, Boston, Massachusetts, 02115, United States

Answer: XenoTherapeutics's phone number is 16*********

Answer: XenoTherapeutics's official website is https://xenotherapeutics.org

Answer: XenoTherapeutics's revenue is Under $1 Million

Answer: XenoTherapeutics's SIC: 8733

Answer: XenoTherapeutics's NAICS: 541714

Answer: XenoTherapeutics has 1-10 employees

Answer: XenoTherapeutics is in Biotechnology

Answer: XenoTherapeutics contact info: Phone number: 16********* Website: https://xenotherapeutics.org

Answer: XenoTherapeutics is a not-for-profit, clinical-stage regenerative medicine company developing innovative cell and tissue-based research solutions. Our FDA-accepted pathogen screening and validated assays provide a robust regulatory pathway for the clinical advancement of xenogeneic cells, tissues, and organs. We accelerate the development, testing, training, and commercialization of innovative, live biotherapeutic products that deliver on the promise of regenerative medicine.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access